0001104659-22-035171.txt : 20220317
0001104659-22-035171.hdr.sgml : 20220317
20220317192011
ACCESSION NUMBER: 0001104659-22-035171
CONFORMED SUBMISSION TYPE: 5/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220317
DATE AS OF CHANGE: 20220317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SILBER ALLAN C
CENTRAL INDEX KEY: 0001009161
FILING VALUES:
FORM TYPE: 5/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39373
FILM NUMBER: 22750507
MAIL ADDRESS:
STREET 1: C/O COUNSEL CORPORATION
STREET 2: 700 - 1 TORONTO ST.
CITY: TORONTO
STATE: A6
ZIP: M5C 2V6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: POINT Biopharma Global Inc.
CENTRAL INDEX KEY: 0001811764
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850800493
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
BUSINESS PHONE: (647) 401-2182
MAIL ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
FORMER COMPANY:
FORMER CONFORMED NAME: Therapeutics Acquisition Corp.
DATE OF NAME CHANGE: 20200511
5/A
1
tm229625-1_5aseq1.xml
OWNERSHIP DOCUMENT
X0306
5/A
2021-12-31
2022-02-14
0
0
0
0001811764
POINT Biopharma Global Inc.
PNT
0001009161
SILBER ALLAN C
4850 WEST 78TH STREET
INDIANAPOLIS
IN
46268
1
1
1
0
Executive Chairman
Common Stock
538087
I
Trustee
This Form 5 is being amended to remove the previously reported transaction involving the shares of Common Stock held indirectly by the Reporting Person as trustee, which was included in error, and to correct the number of shares of Common Stock held indirectly by the Reporting Person as trustee.
Held in a trust for which the Reporting Person is the trustee.
William L. Demers, by Power of Attorney for Allan C. Silber
2022-03-17